1. <nav id="cvlph"><video id="cvlph"></video></nav>
      <object id="cvlph"></object>
      <pre id="cvlph"></pre>

        1. <object id="cvlph"></object>

            About Chance

            Chance Pharmaceuticals is a clinical-stage biotechnology company focusing on discovering, developing
            and commercializing transformative inhalation therapies for the world’s most debilitating diseases

            Founded in 2015 by a team of passionate and experienced experts in inhalation therapy, our vision is to
            harness the potential of inhalation therapy to improve and transform the lives of
            people living with the diseases for which more treatment options are needed.

            History

            2021

            Closed a license-in deal with Aerami Therapeutics for PAH treatment

            2020

            Completed B round financing of about $12M in January 

            Listed as the Quasi-unicorn company in Hangzhou in 2019 and 2020

            Completed pivotal BE study for CXF11

            2019

            Completed a pilot BE study for CXF11 in November

            2018

            Selected as one of the 60 most valuable companies for investment in Zhejiang Province by Hurun Research Institute

            2017

            Closed A round financing of $8M in December

            2016

            Secured seed financing in April

            2015

            Founded in October 2015 in Hangzhou as a start-up biotech company focusing on inhalation therapies

            Leadership

            Dr. Donghao Chen
            Founder and CEO
            Dr. Lan Chen
            co-founder and SVP
            Mr. Peng Huang
            co-founder and VP

            Awards

            Won the "China's Top 80 Healthcare Innovation Enterprises" in 2020

            Recognized as a small and medium-sized science and technology enterprise

            Selected as a quasi-unicorn enterprise in Hangzhou in 2020

            Won the third place in the Zhejiang Province Division of the National Innovation and Entrepreneurship Competition and the National Outstanding Award in 2019

            Won the title of Hangzhou "Young Eagle Plan" Enterprise in 2016

            Listed as the first top 60 recipients for "Kunpeng Plan"  in future technology city in Hangzhou in 2018

            欧美老肥婆牲交videos-欧美人与动人物牲交-亚洲国产精品久久艾草-男人边吃奶边做好爽免费视频

            1. <nav id="cvlph"><video id="cvlph"></video></nav>
              <object id="cvlph"></object>
              <pre id="cvlph"></pre>

                1. <object id="cvlph"></object>